KRT18P51: A Potential Drug Target and Biomarker (G391703)
KRT18P51: A Potential Drug Target and Biomarker
Keratin 18 (K18) pseudogene 51 (KRT18P51) is a gene that encodes a portion of the keratin protein, a protein that is found in the hair, nails, and skin. KRT18P51 has been identified as a potential drug target and biomarker for various diseases , including cancer, neurodegenerative diseases, and autoimmune disorders.
The hair and nail follicles are the primary sites of hair and nail growth, and they are crucial for maintaining the dignity and beauty of the body. The loss of hair and nails can be a sign of aging, but they can also be a symptom of various underlying conditions, such as cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, identifying potential drug targets and biomarkers for these conditions is of great interest.
KRT18P51 is a gene that encodes a portion of the keratin protein. The Keratin protein is a structurally complex protein that plays a vital role in the maintenance of the hair and nail functions. It is composed of several subunits that are arranged in a specific sequence to form a well-coiled structure. The KRT18P51 gene encodes a 51 amino acid residue portion of the Keratin protein.
Studies have shown that KRT18P51 is involved in various physiological processes, including cell growth, differentiation, and survival. It has been shown to play a role in the regulation of cell proliferation and differentiation, as well as in the maintenance of the extracellular matrix (ECM ) structure of cells.
In addition to its role in cell biology, KRT18P51 has also been shown to be involved in the development and maintenance of the hair and structures. It has been shown to be involved in the regulation of the growth and differentiation of hair and nail follicles, as well as in the maintenance of the structure and function of the hair and nail tips.
Given its involvement in various physiological processes, KRT18P51 has been identified as a potential drug target for various conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that KRT18P51 is involved in the development and progression of cancer, and that inhibiting its activity may be an effective way to treat cancer. Additionally, KRT18P51 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and may be a potential target for these conditions.
Furthermore, KRT18P51 has also been shown to be involved in the regulation of autoimmune disorders, such as rheumatoid arthritis and psoriasis. It has been shown to play a role in the development and maintenance of autoimmune tolerance, and may be a potential target for these conditions.
In conclusion, KRT18P51 is a gene that encodes a portion of the Keratin protein. It has been shown to be involved in various physiological processes and has been identified as a potential drug target for various conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of KRT18P51 in these conditions and to develop effective treatments.
Protein Name: Keratin 18 Pseudogene 51
The "KRT18P51 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT18P51 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P | KRTAP1-1 | KRTAP1-3 | KRTAP1-4 | KRTAP1-5 | KRTAP10-1 | KRTAP10-10 | KRTAP10-11 | KRTAP10-12 | KRTAP10-2 | KRTAP10-3 | KRTAP10-4 | KRTAP10-5 | KRTAP10-6 | KRTAP10-7
